Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: Editorial [Hot Topic: Recent Developments and Future Directions in the Treatment of Systemic Rheumatic Diseases (Guest Editor: Minoru Satoh) ]
Volume: 6 Issue: 4
Author(s): Minoru Satoh
Affiliation:
Export Options
About this article
Cite this article as:
Satoh Minoru, Editorial [Hot Topic: Recent Developments and Future Directions in the Treatment of Systemic Rheumatic Diseases (Guest Editor: Minoru Satoh) ], Endocrine, Metabolic & Immune Disorders - Drug Targets 2006; 6 (4) . https://dx.doi.org/10.2174/187153006779025784
DOI https://dx.doi.org/10.2174/187153006779025784 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management
Current Pharmaceutical Design Gene Therapy and Cell Reprogramming For the Aging Brain: Achievements and Promise
Current Gene Therapy Advances in the Treatment of Neurodegenerative Disorders Employing Nanoparticles
Recent Patents on Drug Delivery & Formulation Editorial (Point-of-Care Technologies and their Global Health Applications)
Current Pharmacogenomics and Personalized Medicine Protective effects of andrographolide derivative AL-1 on high glucose-induced oxidative stress in RIN-m cells
Current Pharmaceutical Design Treatment of Estrogen Receptor-Positive Breast Cancer
Current Medicinal Chemistry Antimutagenic, Antiproliferative and Antioxidant Properties of Sea Grape Leaf Extract Fractions (<i>Coccoloba uvifera</i> L.)
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab
Current Drug Targets Novel Inflammatory Biomarkers in Coronary Artery Disease: Potential Therapeutic Approaches
Current Medicinal Chemistry Drug Induced Weight Gain, an Impediment to Successful Pharmacotherapy: Focus on Antipsychotics
Current Drug Targets Biological Effect of Glycosyl-Oxadiazolinethione and Glycosyl-sulfanyloxadiazole Derivatives through their in vitro Inhibition of Glycosidases from Bacteria and Normal or Diabetic Rats
Letters in Drug Design & Discovery Fibromyalgia: Mechanisms, Current Treatment and Animal Models
Current Pharmaceutical Biotechnology Three Dimensional Molecular Field Analysis of Thiomorpholine Analogs of TACE Inhibitors Using Receptor Based Alignment
Letters in Drug Design & Discovery Anti-inflammatory Effect of Electro-acupuncture via Reduction in Colonic Peristalsis in a Mouse Model of Inflammatory Bowel Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Beyond the Synapse and Hebb's Rule: Is the Rest of the Neuron More Important for Psychiatric Disorders?
Current Psychiatry Reviews New Features in the Treatment of Androgen-Independent Prostate Cancer
Current Pharmaceutical Design Cell Life Versus Cell Longevity: The Mysteries Surrounding the NAD+ Precursor Nicotinamide
Current Medicinal Chemistry Signal Transduction via Cannabinoid Receptors
CNS & Neurological Disorders - Drug Targets Neuroplasticity Regulation by Noradrenaline in Mammalian Brain
Current Neuropharmacology Drug-Induced Hypokalaemia
Current Drug Safety